Varroa mite – the tiny terror of honeybee colonies

Varroa mite – the tiny terror of honeybee colonies

Continue reading →

Will Monkeypox trigger a similar C19 scenario?

Will Monkeypox trigger a similar C19 scenario?

Continue reading →

Drug approval in the healthcare markets EU vs. US

Drug approval in the healthcare markets EU vs. US

Continue reading →

Market opportunities in wearable tech

Market opportunities in wearable tech

Wearable technology might well be the answer for false negatives or inconclusive diagnostics tests. As a result of the Covid-19 pandemic, there is a growing demand for non-invasive accurate diagnostics. This is needed in hospitals as well as in homes. A...

Continue reading →

Liquid biopsies – an unbiased diagnosis

Liquid biopsies – an unbiased diagnosis

Scientists in the US have carried out liquid biopsy (as opposed to tissue biopsy) research throughout the summer of 2020 in order to learn how to diagnose cancer through the use of blood tests. The tests are referred to...

Continue reading →

Competition lowers drug prices, FDA says

Competition lowers drug prices, FDA says

According to a report by the US Food and Drug Administration (FDA), increased generic drug entry will lead to price reductions in the market (see our table below) as well as huge savings opportunities for patients, or at least...

Continue reading →

Will the FDA speed up the approval of new drugs?

Will the FDA speed up the approval of new drugs?

The Food and Drug Administration (FDA - US healthcare regulator) will endeavour to review many drugs applications in the next year in relation to coronavirus, but concerns are emerging that if the FDA follows its old ways it will...

Continue reading →